Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC Homeopathy Group Revises Label Disclaimers In Light Of FTC Scrutiny

Executive Summary

American Association of Homeopathic Pharmacists says its new recommended disclaimer for product labels – saying claims are not based on accepted medical evidence – is supported by research showing the language is clear to consumers. 

You may also be interested in...



Homeopathic Dissolvable Strip Firm Shut Down By FTC Will Relaunch After Settling

"It's pretty agonizing now. Our plan is to settle with them as fast as possible and move forward," says Jason Cardiff of Redwood Scientific Technologies in Upland, Calif. FTC alleges firm made unsubstantiated claims for dissolvable film strips for smoking cessation, weight loss and sexual performance; billed customers for unauthorized sales; made "abusive telemarketing through robocalls"; and stated false earnings claims to attract multilevel marketing distributors.

Homeopathic Industry Loses Longtime Leader And Advocate, Jack Borneman

American Association of Homeopathic Pharmacists says Borneman "contributed to monumental changes in the development of homeopathic drugs and their regulation" and "represented and defended homeopathy against uninformed regulation and vanity medical products masquerading as homeopathic."

US FDA Moves Homeopathic Drug Enforcement To Risk-Based Approach

Products with routes of administration other than oral and topical or intended to be used for the prevention or treatment of serious or life-threatening diseases and conditions will be among those prioritized for enforcement and "regulatory actions," draft guidance notes.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS123382

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel